S-Ray Announces Completion of “Testing the Waters” Campaign

REDMOND, Wash., Aug. 15, 2016 (GLOBE NEWSWIRE) -- S-Ray Incorporated announced today that it has completed its "Testing the Waters" campaign.

S-Ray launched its “Testing the Waters” campaign on July 20 in order to gauge potential investor interest in a going public transaction – an IPO via Regulation A Plus Tier II. Through an IPO, S-Ray intends to raise up to $50 million of additional capital to support growth strategies and operational goals. S-Ray’s intention is to proceed with the filing of a Regulation A Plus with the Securities and Exchange Commission (SEC).

To help the Company prepare for an IPO, S-Ray has retained the Newport Beach offices of Anton & Chia, a registered PCAOB, CPAB, ICABC and AICPA firm for the company’s audit. It has also retained the services of New York law firm Foley Shechter LLP to advise the Company on due diligence matters, books and record keeping.

“We are gratified at the speed with which we completed this phase of our IPO,” says Steve Baird, CEO of S-Ray. “That testifies to the depth of our reach within the dental community, which also happens to be a healthy portion of our shareholders. It also points to the fact that we are offering the industry something dental clinicians and professionals need and want: A safe, radiation-free way to scan and image the human mouth.”

About S-Ray Incorporated
S-Ray Incorporated is a biotech dental company that is developing a low cost 3D imaging system for use by dentists. The products will arrive on the market at a crucial juncture — providing low cost 3D imaging for the dental industry. S-Ray was founded in 2008 and is located in Redmond, Washington, where it is part of the Seattle-area’s “ultrasound cluster,” a collection of businesses, research facilities, organizations and more, all of whom are centered around the development of ultrasound technology. S-Ray Incorporated has been issued its first patent, which provides coverage for the unique way of using ultrasound for dental applications. An additional 31 provisional patents have been secured for other aspects of the system and additional software. Learn more about the company and its breakthrough use of ultrasound for dental imaging at www.s-rayinc.com.

Forward-looking & Safe Harbor Statement
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. S-Ray cautions that these forward-looking statements are further qualified by other factors. S-Ray undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.

Contact: David Row 503.341.1285 davidr@s-rayinc.com

Source:S-Ray Incorporated